The coronary stent technology developer, backed by GE and St Jude Medical, has raised $25.8m in a round expected to close at $30m.

Micell Technologies, a US-based vascular stent developer backed by industrial equipment provider General Electric and medical device producer St Jude Medical, has raised $25.8m in equity and debt financing according to a securities fiiling.

Micell is seeking to raise $30m in equity and debt in the round, which has so far received funding from 51 investors, the filing states.

Founded in 1995, Micell is the developer of a fluid-based stent used to deliver drugs in medical devices that treat cardiovascular…